What Are the Top Questions in ALL?
The HemOnc Pulse
Treatment Options for Relapse Disease in ALL
The chapter discusses the current treatment options for relapsed disease in acute lymphoblastic leukemia (ALL), including CAR-T therapy, allogeneic transplant, and newer drugs and novel therapies targeting CD-19, CD-22, CD-20, and BCL-2 inhibitors.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
